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Preclinical work has long focused on male animals,
though biological sex clearly influences risk for
certain diseases, including many psychiatric disor-
ders. Such disorders are often treated by drugs tar-
geting the CNS norepinephrine system. Despite roles
for noradrenergic neurons in behavior and neuropsy-
chiatric disease models, their molecular character-
ization has lagged. We profiledmouse noradrenergic
neurons in vivo, defining over 3,000 high-confidence
transcripts expressed therein, including druggable
receptors.We uncovered remarkable sex differences
in gene expression, including elevated expression of
the EP3 receptor in females—which we leverage to
illustrate the behavioral and pharmacologic rele-
vance of these findings—and of Slc6a15 and
Lin28b, both major depressive disorder (MDD)-asso-
ciated genes. Broadly, we present a means of tran-
scriptionally profiling locus coeruleus under baseline
and experimental conditions. Our findings under-
score the need for preclinical work to include both
sexes and suggest that sex differences in noradren-
ergic neurons may underlie behavioral differences
relevant to disease.
INTRODUCTION
Numerous neuropsychiatric and neurodevelopmental diseases
demonstrate a skew in incidence between sexes, including a
female predominance of major depressive disorder and general-
ized anxiety disorder (MDD and GAD, respectively) (Kessler
et al., 2005), and a male predominance of attention-deficit/
hyperactivity disorder and autism spectrum disorders (ADHD
and ASDs, respectively) (Christensen et al., 2016; Fombonne,
2009). Sex differences in reproductive behavior have been thor-
oughly attributed to sexually dimorphic brain regions; however,
questions remain as to whether more modest behavioral
differences—especially those relevant to common psychiatric
disorders—are mediated by transcriptional sex differences in
key neuronal populations.
The locus coeruleus (LC)—a small nucleus of neuromodula-
tory neurons whose projections release norepinephrine (NE)
throughout the CNS—is implicated in a broad range of functions,
including learning, novelty detection, arousal, anxiety, and fever
(Sara, 2009). Given these extensive neurobehavioral roles, it is
perhaps unsurprising that the LC-NE system has been broadly
implicated in psychiatric disorders and animal models of them.
For example, depression is often modeled in rodents using
pro-inflammatory compounds including interleukins and lipo-
polysaccharide (LPS). LPS, besides inducing fever, is known to
induce substantial activation of the LC and other noradrenergic
cell types (established by Hare et al., 1995). Interleukin-6, a com-
mon upstream pro-inflammatory messenger, was recently found
to directly trigger tonic firing of the LC, eliciting depressive be-
haviors via activation of alpha-adrenergic receptors (Kurosawa
et al., 2016). Tonic firing of the LC in response to corticotropin-
releasing factor (CRF) or optogenetic stimulation can also induce
acute aversive and anxiety-like behaviors (McCall et al., 2015,
2017; Seo and Bruchas, 2017). Sex differences in behavioral
responses to stress have been attributed to molecular-level
differences in CRF signaling via the LC (Bangasser et al., 2011;
Valentino and Bangasser, 2016). In the clinical setting, evi-
dence-based practices offer a robust demonstration of the
involvement of LC dysregulation—or its ability to normalize dys-
regulation occurring elsewhere—in psychiatric disease, given
the use of NE-modulating drugs in depression, anxiety, atten-
tion-deficit/hyperactivity disorder, and addiction. Altogether, a
comprehensive transcriptomic profile of the LC is of substantial
interest for understanding, and potentially targeting, the molec-
ular functions of these cells.
To date, sex differences in the rodent LC have been observed
at both the single-gene and the structural level. Sex differences
in stress response have been attributed to differential CRF sensi-
tivity and CRF receptor trafficking in mouse LC (Curtis et al.,
2006; Valentino et al., 2012), including sex-differential effects
of CRF1 agonism on LC excitability (Bangasser et al., 2016).
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m opioid receptors are also highly expressed in the LC; m agonism
completely suppresses firing of the LC in male, but not female,
mice (Guajardo et al., 2016). Reports of structural dimorphism
in the rodent LC have been ambiguous, with reports of the LC be-
ing larger in either sex, depending on the strain of rat (compare
Babstock et al., 1997; Bangasser et al., 2011; and Luque et al.,
1992). These repeated demonstrations of sex differences in
particular aspects of LC structure and function compelled us
to study both sexes in our pursuit of characterizing LC gene
expression.
In order to transcriptionally profile the LC, we generated a
translating ribosome affinity purification (TRAP) line. We identi-
fied dozens of potential LC-specific drug targets and validated
a subset of these with independent methods. We identified
differentially expressed genes (DEGs) in the LC following LPS
stimulation, demonstrating the utility of this line and method to
detect pharmacologically mediated changes in gene expression
in the LC. To our surprise, we discovered a comparable number
of DEGs between sexes as well. In order to demonstrate that
these transcript-level sex differences in the LC correspond to
consequent physiologic differences, we modulated a receptor
upregulated in female LC, EP3 (encoded by Ptger3). Using elec-
trophysiology and behavior experiments in cannulated mice, we
demonstrate that the EP3 agonist sulprostone acts more
strongly in female mice to suppress tonic firing of LC neurons
ex vivo and to specifically inhibit an LC-mediated stress
response in females in vivo. Thus, we demonstrate previously
unidentified sex differences in gene expression in NE neurons
at a magnitude capable of influencing neurophysiology and
pharmacologic responses. These molecular sex differences at
the level of LC neurons may guide future investigations into
models, mechanisms, or treatments for sex-skewed psychiatric
diseases.
RESULTS
Generation and Validation of Reagents for
Transcriptional Profiling of Noradrenergic Neurons
We generated a mouse line for transcriptional profiling of norad-
renergic neurons by expressing EGFP/RPL10A from a NE reup-
take transporter (Slc6a2) bacterial artificial chromosome (BAC).
Neuroanatomical characterization revealed robust transgene
expression in the A4 and A6 subdivisions of the LC (Figures
1A–1C), where EGFP/RPL10A perfectly co-localized with the
LC-specific NE-synthesizing protein, DßH (Figure 1D), along
with reasonably robust co-labeling in the A5 and A7 groups.
EGFP/RPL10A labeling was weak and sparse in more caudal
DßH+ populations (e.g., A1 and A2), consistent with prior immu-
nofluorescence studies of SLC6A2 expression (Schroeter et al.,
2000). Little EGFP expression was seen in ependymal cells,
except rarely in cells caudal to the fourth ventricle (data not
shown), in contrast to previously reported ependymal expression
of SLC6A2. In total, this anatomical characterization asserts that
mRNA collected by TRAP will be from the most robustly labeled
and populous cells: the A4–A7 groups, predominantly the LC.
We then performed TRAP on two Slc6a2 founder lines to
evaluate consistency, to confirm enrichment of known LC-spe-
cific transcripts by TRAP, and to identify transcripts enriched in
LC compared to the hindbrain. Reproducibility was strong be-
tween the lines (Pearson correlation > 0.99; Figure 1E). Relative
to whole-hindbrain RNA from the same mice, TRAP enriched
for genes with known specificity and functionality in the LC
(Figure 1F), including (1) enzymes related to NE turnover
(Th, Ddc, Maoa, and Dbh), (2) vesicular monoamine (Slc18a2)
and NE (Slc6a2) transporters, (3) galanin (Gal) and its receptor
(GalR1), and (4) a transcriptional regulator of LC development
(Phox2a). After conservative filtering for expression and back-
ground, at least 3,139 transcripts were detected with high con-
fidence in NE neurons; 526 were enriched >2-fold compared to
hindbrain.
Gene Ontology (GO) analysis was applied to broadly charac-
terize NE neuron-enriched transcripts, revealing enrichment of
transmembrane receptors and ligands (Figure 1H), consistent
with prior observations that CNS cell-type-specific genes often
include receptors (Doyle et al., 2008). These LC-enriched re-
ceptors are highlighted (Table S1B), given the importance of
the LC—and extrinsic modulation thereof—in behavior. Next,
transcriptional profiles of LC and other CNS cell subtypes pre-
viously characterized by TRAP were compared to predict
genes specific to the LC compared to other cells in the brain
and the ‘‘transcriptional ontology’’ of the LC using our previ-
ously described pSI (specificity index p value) algorithm (see
Experimental Procedures). Compared to all other available
cell types, 162 genes scored as LC enriched (pSI < 0.05),
with 78 highly so (pSI < 0.005) (Figure 2A; Table S1A). Hierar-
chical clustering placed noradrenergic cells with other neuro-
modulatory populations (Figure 1G), including serotonergic,
hypocretinergic (Hcrt), and forebrain cholinergic neurons. The
shared transcriptional relationship with Hcrt neurons is striking;
despite their anatomic separation and the use of distinct neuro-
transmitters, they form reciprocal connections and share func-
tional roles in control of sleep and arousal (reviewed in Carter
et al., 2013), supporting the notion that gene expression in
neuronal cell subtypes is a strong predictor of a subtype’s
functional roles.
Transcripts identified as LC enriched (Figure 2A) were then
validated using standard RNA and protein detection methods
in wild-type mice. In situ hybridization (ISH) for Calcr selectively
and robustly stained the LC (Figure 2B), consistent with microar-
ray results, suggesting very high enrichment of Calcr in the LC
compared to hindbrain (over 300-fold). As the characteristic
‘‘quarter-moon’’ anatomy of the LC could be readily discerned
by ISH, additional transcripts were systematically evaluated for
enrichment using The Allen Brain Atlas (Figures 2C and S1).
70% of TRAP transcripts showed enriched in situ staining in
the LC; over 19% scored as having ‘‘marker-like’’ expression.
Finally, we confirmed protein translation in the the LC of several
identified genes using immunofluorescence (Figure 2D).
Transcriptional Responses of NENeurons to LPSCanBe
Identified with Slc6a2 TRAP
Having verified that TRAP characterizes baseline transcriptional
features of the LC, we next sought to demonstrate the utility of
this mouse line for profiling changes consequent to stimulation
of the LC. LPS is a well-characterized example of an LC-acti-
vating stimulus: it strongly increases FOS expression in the LC,
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and the LPS-induced febrile response is lost with LC ablation
(Almeida et al., 2004). Therefore, we injected individual TRAP
mice with LPS or vehicle in a sex-balanced design. Whole-hind-
brain RNA from the same lysates served as controls, as did a
parallel TRAP experiment with Slc6a4 TRAPmice targeting hind-
brain serotonergic neurons (Figure 3).
We first examined whole-hindbrain changes in response to
LPS (Figure 3B); 56 genes showed a response, predominantly
upregulation (Table S1C). GO analysis identified a significant in-
crease of interferon-induced transmembrane proteins (Fig-
ure S2), consistent with a broad pro-inflammatory transcriptional
response. However, examination of Slc6a2 TRAP revealed an
even greater response (Figure 3C; Tables S1D and S1E), largely
distinct from that of the hindbrain (only two genes were shared
Figure 1. Characterization of Noradrenergic
bacTRAP Lines
(A) Anti-GFP immunohistochemistry demonstrates
EGFP/Rpl10a labeling in the hindbrain.
(B) Anti-GFP staining is most robust in anterior
groups (A4–A7), especially LC.
(C) Immunofluorescence for GFP (green) labels
entire LC. Scale bar, 200 mM.
(D) GFP co-labels completely with dopamine-
b-hydroxylase (DBH) (red). Scale bar, 50 mM.
(E) Comparison of two Slc6a2 TRAP lines demon-
strates reproducibility.
(F) Slc6a2 TRAP mRNA versus total hindbrain
mRNA enriches NE neuron markers (blue) and
depletes unrelated cell-type (glial) markers (red).
(E and F) Lines indicate 0.5-, 1-, and 2-fold. Log10
scale.
(G) Hierarchical clustering of Slc6a2 neurons.
(H) Slc6a2 TRAP enriches for transmembrane
proteins and receptors. Hypergeometric test,
Benjamini-Hochberg corrected; *p < 0.06;
**p < 0.01.
See also Table S1B.
between hindbrain and LC). In contrast,
response of serotonin neurons was
limited (Figure 3B). Given the multitude
of psychopharmacotherapeutics and
environmental stimuli—including inflam-
mation, pain, and acute stress—known
to modulate the LC, these findings
establish a useful system for identifying
LC-specific molecular responses to
whole-animal manipulations.
Noradrenergic Transcriptional
Profiles Reveal Robust Sex
Differences
To our surprise, sex-stratified analyses of
these same experimental data revealed
substantial sex differences in noradren-
ergic neurons. First, analysis of transcrip-
tional profiles of thewhole hindbrain varied
remarkably little between sexes, with the
exception of a few sex chromosomal
genes (Figure 3C). Likewise, serotonin neurons showed no appre-
ciable differences outside of sex chromosomal transcripts (e.g.,
Ddx3y and Eif2s3y). In contrast, noradrenergic neurons showed
substantial molecular sex differences: a total of 152 transcripts
were DEGs, most of which are autosomal (Figures 3D and 3E;
Tables S1F andS1G), and these did not overlapwith the serotonin
neurondifferential transcripts.These transcriptsalsodonot signif-
icantly overlap with those stimulated by LPS, nor are they charac-
terized by similar functional categories (Figure S2). This indicates
that the observedmolecular divergence is not likely due to sex dif-
ferences in baseline activity level of the LC but rather reflects a
more complex molecular distinction between the sexes. Moti-
vated by the clear role of sex as a risk factor for psychiatric disor-
ders, we focused on these sex differences for additional study.
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Figure 2. Transcript and Protein Expression in LC Neurons
(A) Top 45 named genes enriched by TRAP over hindbrain (adjusted p value), fold change (TRAP/Hind), and specificity index p value (pSI) comparing Slc6a2 to
all cell populations from Figure 1G (see also Table S1A).
(B) ISH confirms LC enrichment of calcitonin receptor. 4V, fourth ventricle; scp, superior cerebellar peduncle; 2cb, cerebellar vermis.
(legend continued on next page)
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Sex-Differential LC Genes and Putative cis-Regulators
Implicated in Disease and Behavior
As a preliminary investigation into possible gene-regulatory
mechanisms underlying sex differences in LC gene expression,
we characterized DNA sequence motifs in cis with these 152
genes. Performing de novo motif discovery for DEGs from
each sex, we identified 12 motifs (Table S2). Compared to their
frequency near 1,000 randomly selected genes, six of these
were significantly enriched near the DEGs. Thus, at least a
portion of the sex differences in gene expression could be ex-
plained by conserved cis-regulatory elements in the surrounding
genome. Known transcription factor binding sites predicted in
these motifs included OTX2, NR2F6, and MTF1 (Table S2).
Molecular Differences Predict Functional Differences
between Sexes
Finally, we noted LC specificity and female LC enrichment
(>2-fold; Table S1E) of the Ptger3 gene, encoding the prosta-
glandin E2 (PGE2) receptor EP3. Given the specificity of this
gene’s expression to the LC (Table S1A) within the hindbrain
and the existence of a known, selective agonist, sulprostone,
we selected EP3 to pharmacologically test whether the magni-
tudes of detected sex differences in receptor gene expression
were adequate to alter LC electrophysiology and/or behavior.
We first assessed whether pharmacologic manipulation of the
EP3 receptor resulted in sex-differential electrophysiologic re-
sponses by performing whole-cell recordings from LC neurons
in ex vivo slices. EP3 presence in the LC was confirmed—and
subsequently manipulated—by bath application of sulprostone
(agonist), followed by L798,106 (antagonist) to displace sulpro-
stone, halting its effects. Sulprostone suppressed baseline tonic
firing of LC neurons in both sexes, but with a greater magnitude
and duration of hyperpolarization in female LC compared tomale
LC (Figures 4A and 4B). Voltage-clamp recordings from a sec-
ond cohort of mice revealed a larger outward current from female
LC neurons (Figures 4C and 4D), verifying that the magnitude of
LC inhibition by EP3 corresponds to sex differences in Ptger3
expression.
We previously showed in male mice that LC silencing with Gi-
coupled designer receptors exclusively activated by designer
drugs (DREADDs) prevents anxiety-like behavior in theopen-field
task (OFT) after restraint stress (McCall et al., 2015). This behav-
ioral paradigmprovided a robustmodel system inwhichwecould
activate the LC in vivo, and subsequently attempt to suppress the
LC pharmacologically, with behavior as the outcome measure.
We first validated that restraint stress robustly induces anxiety-
like behavior (avoidance of center) in the OFT in mice of both
sexes (Figures 4E and 4H). Restraint stress did not impact total
activity or the sex difference therein but clearly induced avoid-
ance of center in both sexes. Thus, we hypothesized that EP3
agonists could be used to reduce stress-induced anxiety, specif-
ically in wild-type female mice. Indeed, administration of sulpro-
stone via cannula to male and female LC immediately before
restraint stress and OFT resulted in selectively reduced anxiety-
like behavior in females (Figures 4I–4L). Post hoc analysis of
phosphorylated-FOS (p-FOS) expression in TH+ neurons of the
LC in the same animals revealed similar staining intensity of
p-FOS and numbers of double-positive cells between sexes
(data not shown). The robust immediate-early response in both
conditions is consistent with intact stimulation of LC neurons by
stress, suggesting that sulprostone inhibits noradrenergic
output. Sulprostone did not affect the baseline sex difference in
total ambulatory activity. (Figure 4M).
DISCUSSION
Characterizing gene expression in noradrenergic neurons—
regardless of whether they are at the etiologic root of neuropsy-
chiatric diseases and diseasemodels—is key to narrowing down
possible mechanisms by which NE signaling may be dysregu-
lated in disease states.We have presented amouse line enabling
transcriptional profiling of LC neurons at baseline and after phys-
iologic manipulations (LPS). In characterizing this line, we
discover and herein report a breadth of previously unidentified
sex differences in molecular features of the mouse LC. These
findings highlight the LC as an area of focus for future studies
in neuropsychiatry, especially in domains where sex differences
are observed in modeled behaviors or diseases. In contrast, we
find that serotonergic neurons show few sex differences in gene
expression, despite their hypothesized role in behavior and psy-
chiatric disease. Sex-differential expression of one such recep-
tor, PTGER3, was adequate in magnitude to sex-differentially
affect electrophysiologic and behavioral pharmacologic re-
sponses. This independent verification of our transcriptomic
findings suggests that sex-differentially expressed genes in the
LC (1) may underlie sex differences in behavior and behavioral
pathology and (2) can be targeted to sex-specifically modulate
LC-mediated behaviors. Thus, we conclude that the LC is an
interesting candidate for mediating sex differences in mono-
amine-associated psychiatric phenotypes. We further envision
that this mouse line could provide an invaluable tool in studies
aimed at identifying mechanisms of existing NE-targeting drugs
at the transcriptomic level and enable prioritization of new, pre-
cise drug targets aimed at the same transcriptional endpoints.
Our profiling extends previous work illustrating discrete mo-
lecular sex differences in the LC. Perhaps best characterized is
the trafficking of receptor CRF1 and response to its ligand,
CRF (Bangasser et al., 2016; Curtis et al., 2006; Valentino
et al., 2012). Likewise, the expression of the m-opioid receptor
and response to opioid agonism in the LC shows a sex difference
(Guajardo et al., 2016). Estrogen regulates genes required for NE
synthesis in a sex-specific fashion (discussed later). Structural
dimorphism in the rat LC has also been observed, though the di-
rection of effect depends on the strain of rat (compare Babstock
et al., 1997; Bangasser et al., 2011; and Luque et al., 1992).
Finally, postnatal citalopram exposure in rats causes ectopic
(C) Blind comparison of TRAP-identified and random genes confirms TRAP transcript presence in LC (p < 2.7E38, chi-square test, normalized to number of
n = 53 TRAP-identified transcripts and 94 randomly selected transcripts). Error bars are ± SEM for two independent, blinded scorers (see also Figure S1).
(D) Immunofluoresence confirms translation of TRAP-identified transcripts (green) in LC cells (arrowheads), labeled by either TH or DBH (red).
See also Figure S1 and Table S1A.
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projection of LC fibers into the neocortex and increased LC
excitability in males, but not females (Darling et al., 2011). We
expand upon this body of research by identifying thousands of
genes expressed in the LC and sex differences therein, as well
as recurrent, conserved motifs in cis with these genes.
Among the transcripts with sex differences identified in the LC,
we identified a number of genes and putative cis-regulators
notable for their previous implications in behavior and brain
development. Putative regulators in cis with the DEGs included
three striking candidates: OTX2, NR2F6, and MTF1. OTX2 was
recently shown to regulate depression-related consequences
of early life stress in male mice (females were untested) through
actions in dopaminergic neurons (Pen˜a et al., 2017). MTF1 is
notable for its role in binding and responding to heavy metals,
perturbations of which have been implicated in ASDs (Arora
et al., 2017; Hagmeyer et al., 2015); furthermore, this transcrip-
tion factor was itself enriched in the LC of males, providing hints
of a potential regulator of some of our observed sex differences.
Finally, NR2F6 is a nuclear receptor known to be required for
LC differentiation, consistent with LC enrichment of the genes
used for motif analysis. As the motif analysis only utilized
conserved regions of mammalian sequence near these genes,
these regulatory mechanisms—and, thus, sex differences—
may be conserved in humans.
Intriguingly, we also noted a previously unidentified female
enrichment PGE2 receptor Ptger3 (EP3) in the LC. PGE2 and
PTGER family receptors are known to mediate sexually dimor-
phic neurodevelopment in the preoptic area of the hypothala-
mus (Amateau and McCarthy, 2004; Wright et al., 2008); sex-
differential expression of these receptors in a separate, adult
brain region was, thus, intriguing. The enrichment of PGE2 re-
ceptors is interesting in the context of LPS, which we used
here to stimulate the LC, but also stimulates fever; PGE2 and
the LC are major effectors of LPS-induced fever via the EP3
and EP4 receptors (Almeida et al., 2004; Oka et al., 2000).
Follow-up studies are merited to explore whether the EP3
receptor plays a role in fever effects on behavior via the LC
and whether its differential expression is the cause or conse-
quence of the broader transcriptomic sex differences pre-
sented here.
This expression difference was sufficient tomodulate behavior
in a sex-specific way, which we validated by LC-targeted phar-
macologic manipulation. Using sulprostone to agonize EP3, we
identified strong inhibitory effects on LC firing in female LC neu-
rons, consistent with the pattern of its increased female expres-
sion. We then utilized restraint stress as a validated means of
activating the LC and triggering LC-mediated behavioral
changes (McCall et al., 2015, 2017; Seo and Bruchas, 2017;
Uematsu et al., 2017). In turn, we aimed to suppress restraint-
driven LC activation by administering sulprostone beforehand,
ameliorating behavioral signs of stress-induced LC activity in
female, but not male, mice. Thus, we demonstrate that the sex
differences in receptor expression measured in the LC by
TRAP are of an adequate magnitude to manipulate an LC-regu-
lated behavior in a sex-specific manner.
Our stress paradigmwas only used to robustly activate the LC,
rather than to investigate stress per se. Whether EP3 plays a role
in—or undergoes transcriptional or translational regulation in
response to—physiologic sex differences in the stress response
of the LC remains unclarified. We also note that the mice in which
DEGs were identified were singly housed (potentially a stressor,
i.e., social isolation), and housed at an unstressful, thermonormal
30C for fever experiments. We note, however, that our electro-
physiologic and behavioral findings regarding PTGER3 were
consistent with the observed expression changes, despite the
mice for the later experiments being group-housed at a normal
room temperature. Using these TRAP mice to deliberately study
sex-specific transcriptional/translational responses to stress will
be an interesting application of this mouse line in future
investigations.
It is interesting to speculate that sex differences in LC gene
expression may specifically influence increased female risk of
disorders like GAD and MDD, where NE-modulating drugs
have seen use for decades. If higher baseline expression of
some genes in the female LC promotes risk for MDD, then com-
mon variants that elevate the expression of those same genes
may likewise confer depression risk. Indeed, when we examined
the 15 documented MDD-associated loci (Hyde et al., 2016) for
the presence of sex-differential LC genes, we found two genes
associated with MDD are enriched in LC of female mice:
Slc6a15 and Lin28b. This striking coincidence may imply that
certain sex- and variant-mediated MDD risk factors converge
in the LC. Future research is warranted to explore whether
sex- and disease-associated regulatory variants concordantly
affect gene expression and psychiatric disease risk via LC and
other monoamingergic cell populations.
Overall, the marked molecular sex differences present inter-
esting areas for future inquiry. Most notably, the mechanism of
establishing these sex differences (hormonal-developmental,
sex-chromosomal, or post-pubertal hormonal) remains unclari-
fied. Previous work has shown that estrogen regulates the
expression of Th and Dbh—and, thus, NE synthesis—in a sex-
differential manner in adult rodents (Serova et al., 2002; Thanky
et al., 2002). In the present study, estrous cycling was not exam-
ined for effects on transcriptional sex differences. Regarding
behavior, we note that estrous cycling does not appear to play
a role in most behaviors (Prendergast et al., 2014), including
center time in the open field task for C57BL6 mice (Meziane
et al., 2007); binning behavior data by estrus stage revealed no
substantial differences (Figure S4). Another possible mecha-
nism, the perinatal masculinizing hormonal surge inmale rodents
that organizes other dimorphic regions, might be equally
Figure 3. Differentially Expressed Genes by Sex
(A–C) Scatterplots contrasting transcriptional data between LPS and vehicle (PBS) or sex (A); DEGs are indicated by color. (B and C) Number of DEGs after LPS
(B) (red, up; green, down) or between vehicle-treated sexes (C) in each sample type (see also Tables S1C–S1G).
(D and E) Top 50 named sex-DEGs in LC of females (D) or males (E). M/F or F/M represents fold change between sexes; TRAP/Hind represents fold change, TRAP
versus hindbrain.
See also Figure S2 and Tables S1C–S1G.
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Figure 4. Sex Differences in Ptger3 Expression Can Be Reflected in LC-Mediated Behavior
(A–C) Representative current-clamp (A) and voltage-clamp (C) traces from LC slices exposed to sulprostone (200 nM), followed by L798,106 (300 nM).
(B) Maximum change in membrane voltage (mV) after sulprostone, by sex (10.5 ± 2.1 mV, n = 10 cells from 5 females; 2.6 ± 1.8 mV, n = 9 cells from 4 males;
p < 0.05, Mann-Whitney).
(D) Maximum change in outward current (pA) after sulprostone, by sex (78.5 ± 9.7 pA, n = 10 cells from 3 females; 44.4 ± 8.9 pA, n = 9 cells from 3males; p < 0.05,
Mann-Whitney).
(E) Schematic of validated stress-anxiety paradigm.
(F–H) Effects of restraint stress on OFT task performance (n = 6–7).
(F) Time in center zone.
(G) Center entries.
(H) Total activity.
(I) Timeline of LC pharmacology-behavior experiments.
(J) Representative OFT traces from each sex and treatment condition.
(K and L) Sulprostone administration prevents stress-induced anxiety in female (ns = 17 and 17) but notmale (ns = 16 and 14)mice inOFT; time (K) and center zone
entries (L) (see also Figure S4 for estrous-stage-specific behaviors).
(M) Time in center was unaffected by sulprostone for both sexes.
*p < 0.05; **p < 0.01. All error bars indicate SEM.
See also Figure S4.
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important in the LC—indeed, structural differences in female rat
LC can be attenuated by perinatal testosterone administration
(Guillamo´n et al., 1988). Overall, it is possible that multiple mech-
anisms contribute to the molecular sex differences we detected.
Thus, future studies are warranted, both focusing on identifying




All procedures involving animals were approved by the institutional animal
care and use committees of Rockefeller University, Case Western Reserve
University, and Washington University in St. Louis, MO.
Immunofluorescence Microscopy
Paraformaldehyde (PFA)-perfused mouse brains were dissected, cryopro-
tected, and cut by cryostat into floating sections for immunostaining with
primary antibodies and Alexa fluorophore-labeled secondary antibodies. Anti-
bodies used are described in Table S1J.
TRAP for Initial Description of LC
Replicate pools of fivemixed-sex adult mice from each of theSlc6a2 lines were
sacrificed. Brains were removed for collection of hindbrain posterior to the
pontine/hypothalamic junction (discarding the cerebellum).
All array data were analyzed in R using Bioconductor packages. GCRMA
was used to normalize within replicates and to biotinylated spike-in probes
(green dots, Figure 1F) between conditions. Fold change, specificity index
(SI), and pSI were calculated for genes expressed above non-specific back-
ground, defined as at least 2 SDs above the mean TRAP:hindbrain ratio of
negative control transcripts (Figure 1F, red dots). LC-enriched transcripts
were identified using the empirical Bayesian statistic with false discovery
rate (FDR) correction in limma. The pSI algorithm was used with default set-
tings to compare LC TRAP cells to other cells profiled by TRAP (Figure 1G).
Hierarchical clustering across cell types was conducted in R, utilizing expres-
sion values from genes with pSI < 0.01 in any cell type.
Scoring of The Allen Brain Atlas for LC Gene Specificity
Any transcript that scored between 1 and 3 (examples in Figure S1) was
considered to be marker-like. A chi-square test was performed, comparing
the observed counts of each score with expected counts (based on the
random gene set) for each score.
Single-Animal TRAP for Sex-Differential and LPS-Responsive Gene
Expression
Samples were prepared and hybridized in two batches counterbalanced for
mouse strain, sex, and LPS. After processing, one Slc6a4 TRAP sample and
two hindbrain samples were excluded due to poor hybridization. Remaining
samples were normalized using the lumi package. Appropriate clustering of
replicates was confirmed with multidimensional scaling (MDS) plots (Fig-
ure S5). Differential expression was defined as p < 0.05 on a paired t test
(paired on batch and covariate), and log2 fold change of ± 0.585 across 3 of
4 paired comparisons. For balance, the single Slc6a4 replicate was used twice
to replace the low-quality sample. (Results are given in Tables S1C–S1G.)
To validate this analytic approach, we performed standard differential
expression analysis in limma. Resulting p values for genes identified in the
former analysis in Tables S1C–S1G. Full array results from this analysis are
given in Table S3. The two analyses and locations of their results are also given
in Table S1K.
Motif Analysis of Peri-TSS Sequences of Sex-DEGs in LC
For each sex-differentially expressed gene identified in the LC (Tables S1F and
S1G), mm10 genomic sequences 10 kb 50 and 10 kb 30 to the transcription start
site (TSS) were acquired. Exonic bases in non-conserved regions of sequence
(based on PhyloP scores) were masked out. Masked flanking sequences were
submitted to MEME (Bailey et al., 2015) for de novo discovery of motifs
8–20 bp long. The associated tool, TomTom, was used to compare motifs to
known transcription factor (TF) binding sites (Kulakovskiy et al., 2018; Mathe-
lier et al., 2016; Weirauch et al., 2014). Motif frequency, consensus sequence,
and predicted TFs discussed in the text are provided (Table S2). To assess
motif enrichment near LC transcripts, 1,000 random protein-coding TSSs
were selected and processed identically. These were searched for motif
matches using FIMO at the same p cutoff for a ‘‘match’’ used by MEME during
discovery. The number of unique loci containing R1-motif match among all
loci was then compared using chi-square analysis, followed by Benjamini-
Hochberg correction.
Electrophysiology of LC Neurons Exposed to PTGER3 Agonist/
Antagonist
Whole-cell recordings were made using an Axopatch 200B amplifier (Molecu-
lar Devices). LC neurons were identified by location, capacitance > 40 pF, an
input resistance < 100 MU, and a tonic firing rate of 0.5–4 Hz.
Stereotaxic Cannulation of LC
Micewere allowed to recover from surgery 7–9 days prior to behavioral testing.
Animals were also habituated to handling and connection to tubing for 3
consecutive days prior to behavioral testing.
Stress-Induced Anxiety Behavioral Paradigm
Anymaze was used for video recording of animal movements for center and
periphery analysis. The center zone was defined as a concentric rectangle
comprising 50% of the OFT area. Cannula placement was confirmed by cryo-
stat sectioning of perfused brains (Figure S3) to determine mice for inclusion in
the final behavioral and p-FOS analyses.
c-FOS Quantification in LC following Sulprostone/Vehicle,
Restraint, and OFT
Gain, light intensity, and exposure time were identical for all prepared micro-
scope slides. Using ImageJ, background was subtracted, ROIs were made
around the LC based on tyrosine hydroxylase (TH) staining, and average pixel
intensity for p-FOS fluorescence was measured. p-FOS-TH double-positive
cells were counted manually by a blinded experimenter.
DATA AND SOFTWARE AVAILABILITY
The accession number for the transcriptomic data reported in this paper is
GEO: GSE100005 (https://www.ncbi.nlm.nih.gov/geo/).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and three tables and can be found with this article online at
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Figs. S1 to S5 and legends 
Table S2 and legend 




Table S1 (separate .xls file with 9 sheets: 1a-1k) 
Table S3 (separate .xls file with 1 sheet) 
 




Fig. S1: Examples of Allen Brain Atlas In Situ Hybridizations scored 1-5. Related to Figure 2. Images from Allen 
Brain Atlas for examples of in situ hybridizations that would score a 1-5, respectively. Images of whole sections 




Figure S2: Pathway analysis of transcripts altered in hindbrain by LPS and of sex-differentially expressed 
transcripts in noradrenergic neurons. Related to Figure 3. A) A pathway analysis using DAVID reveals the 
hindbrain showed a significant increase of interferon related gene expression, and trends in a variety of chemokine 
and inflammatory pathways. B,C) An exploratory pathway analysis using DAVID illustrates the trends in male and 
female noradrenergic gene lists (-Log10 p-values. No p<0.05 after Benjamini-Hochberg correction for multiple 
testing). Though no individual pathway survived correction for multiple testing, the trend towards more 
mitochondrial genes and vesicular transport transcripts in female neurons may suggest they have slightly higher 
metabolic demands. Male neurons had slightly more nuclear factors, driven by transcription factors such as Atrx1, 







Figure S3: Map of LC cannula placements from post-mortem brain tissue. Related to Experimental 
Procedures. Tissue from all mice cannulated and given sulprostone or vehicle was sliced, and the deepest point of 
the two cannula tracks was noted for each mouse. These points are collectively mapped here for mice across all 
conditions. If cannulae were not in the target area, the mice/tissue were excluded from behavioral analysis, c-FOS 
quantification, and this diagram. Anatomy is shown in the coronal plane with mm along anterior-posterior (AP) axis; 
 dotted lines outline location of the LC. Circle outlines: blue = male, orange = female; fill color: purple = 
sulprostone-treated, empty/white = vehicle-treated. 
 
Figure S4: OFT data by estrus stage from one cohort of sulprostone-behavior mice. Related to Figure 4. 
Boxplots for seven OFT measures in counts, meters (m), or seconds (s) from females in a cohort of sulprostone-
behavior mice with estrus staging data. Bottom and top of boxes represent 25th and 75th percentiles, respectively; 
 line inside the box represents the median (50th percentile), and individual points represent outliers. Metestrus and 
diestrus were combined per (Silva et al., 2016). 
 
 
Figure S5: Multidimensional scaling (MDS) and heatmaps illustrate the clustering of samples and gene sets. 
Related to Figures 1-3 and Experimental Procedures. A) Hierarchical clustering confirms the expected 
segregation of samples by cell/sample type (Slc6a2 vs. Slc6a4 vs. hindbrain, or TRAP vs. hindbrain), and show a 
degree of batch effects, guiding the analytical strategies employed. B) Clustering genes that were DE between at 
least one comparison in the Slc6a2 TRAP samples (i.e., comparing expression between sexes or between LPS/PBS 
conditions) illustrates the presence of distinct LPS-and sex-dependent DEG sets in noradrenergic neurons. The 
adjacent Slc6a4 samples illustrate that sex and LPS do not affect these genes in serotonergic neurons in an 
analogous manner. 
  
Table S2: Motifs discovered in conserved, noncoding regions near sex-DEGs. Related to Experimental 
Procedures. 
Motif: Refers to the sex, algorithm (allowing ≤ 1 or ≥ 1 motif occurrence per query sequence) and the result # in the 
MEME output. Total # motif occurrences found: total number of significant matches for the motif. # Unique 
sequences matching: the number of queried sequences with ≥ 1 motif match out of the total number of sequences 
queried. E-value: a MEME measure of probability compared to a shuffled version of the input sequences. Chi-sq p 
value: from comparative abundance of the identified motif in 1,000 randomly selected, protein-coding gene regions 
subjected to the same masking paradigm. Select TFBS predictions: TFBSes identified using TomTom with 
previously described expression in neural cell types and of functional and/or cell type relevance to the LC. 
Sequence: the position-weight matrix (PWM) given in the MEME results.  
 Supplemental Experimental Procedures 
Animal Research Statement 
All procedures involving animals were approved by the Institutional Animal Care and Use Committees of 
Rockefeller University, Case Western Reserve University, and Washington University in St. Louis.  
 
Generation of LC TRAP mice and selection of an LC-specific TRAP mouse line. We initially modified BACs to be 
controlled by the promoters of either of two genes with LC-specific expression: Dopamine Beta Hydroxylase (Dbh, 
BAC RP23-354N13), involved in the synthesis of NE (16), and the NE reuptake transporter (Slc6a2, RP23-109O23) 
(17). BACs were modified as described (Doyle et al., 2008) to insert the TRAP transgene (EGFP/Rpl10a) at the 
translation start site of the relevant gene. Successful modification was confirmed with Southern blot, and the 
absence of gross rearrangements in the BACs was verified by BAC fingerprinting and pulse field gel. Modified 
BAC DNA was purified with CsCl gradient centrifugation, dialyzed into injection buffer, and injected into FVB 
mouse eggs. Eggs were transplanted into pseudo-pregnant Swiss Webster dams; tail tips of the resultant pups were 
PCR genotyped for EGFP to identify founders. Founders were crossed to C57/BL6J wildtype mice, whose F1 
progeny were genotyped and processed for anatomy as described below. Multiple founder lines were evaluated for 
EGFP expression; lines from both Dbh and Slc6a2 constructs showed EGFP/Rpl10a expression in the LC and other 
noradrenergic populations. The lines for Slc6a2 consistently demonstrated more robust EGFP/Rpl10a expression—
as described in the main text’s results section and Figure 1—and were thus selected for complete anatomical and 
biochemical evaluation. Two of the Slc6a2 founders were used for initial transcriptional profiling (these lines were 
delegated B6;FVB-Tg (Slc6a2-EGFP/Rpl10a)JD1537Jdd/J and B6;FVB-Tg (Slc6a2-EGFP/Rpl10a)JD1538Jdd/J) 
(Figure 1E, 2A). The line JD1538 was further used to contrast transcriptional profiles of LC under different fixed 
and environmental conditions (sex and LPS injection) (Figure 3). 
Immunofluorescence microscopy. Mice were sacrificed then perfused with phosphate buffered saline (PBS) followed 
by 4% paraformaldehyde in PBS. Brains were dissected, cryoprotected in 30% sucrose PBS solution, frozen, and 
sectioned serially on a Leica cryostat into PBS with 0.1% sodium azide for storage at 4°C. Floating sections were 
incubated at room temperature for 30 minutes in a blocking buffer of 5% normal donkey serum and 0.25% Triton in 
PBS followed by overnight incubation with primary antibodies in blocking buffer. Sections were washed 3 times 
with PBS, then incubated for 60-90 minutes with appropriate Alexa fluorophore-conjugated secondary antibodies 
and nuclear dye (DAPI or TOPO-3-Iodide, Life Technologies). Images were acquired on a LSM 510 Zeiss confocal 
microscope or a Perkin Elmer UltraView Vox spinning disk confocal via a Zeiss Axiovert microscope. Antibodies 
used are described in Table S1j. 
Immunohistochemistry. Mice were processed as above. For anti-GFP DAB immunohistochemistry, brains were 
processed utilizing multibrain technology by Neuroscience Associates (Knoxville, TN) as described (Doyle et al., 
2008), using a custom goat anti-GFP antibody and a Nickel enhanced DAB substrate for HRP. Sections were 
digitized with a Zeiss Axioskop2 using customized macros.  
In-situ hybridization (ISH) for detection of Calcr mRNA. Two adult (P>60) C57BL/6J male littermates and one P35 
male FVB-Ant mouse were sacrificed by CO2 asphyxiation. Brains were transferred to cryoprotectant, and stored at 
-80°C for <4 weeks. 20µm cryosections were cut and directly mounted onto slides for ISH. The antisense Calcr 
probe region was selected to complement a constitutive exon. The probe was amplified by PCR with primers 
containing an appropriately-oriented T7 polymerase promoter, and probes were subsequently synthesized by in vitro 
transcription (per mfg. instructions) using T7 polymerase (Promega #P2075) and Digoxigenin RNA Labeling Mix 
(Roche #11277073910). For ISH, slides were incubated in 4% paraformaldehyde for 10min to fix tissue. Probe was 
hybridized to slides in a humid chamber at 68°C overnight and washed. Alkaline phosphatase-coupled anti-
digoxigenin antibodies (Table S1j) were used for detection (4°C overnight incubation), followed by staining with 
NBT and BCIP, resulting in black staining by alkaline phosphatase. Primers for the Calcr probe were: 5’ 
GCCAGTGGACGCAGTTCAAGATCCAGTGG 3’ and 5’ gcacgTAATACGAC- 
TCACTATAGGCCTGCTTTCCTACGAACACAGTCATCTCAGTCC 3’ (in bold lowercase: bases added to end 
to allow room for T7 association, per mfg. instructions; in bold uppercase, the T7 promoter).  
TRAP for initial description of LC. Replicate pools of five mixed sex adult mice from each of the Slc6a2 lines were 
sacrificed. Brains were removed and transferred to ice-cold dissection buffer containing cycloheximide for 
collection of hindbrain posterior to the pontine/hypothalamic junction (discarding the cerebellum). TRAP was 
conducted as described  (Doyle et al., 2008). Briefly, each pooled sample of hindbrains was homogenized in buffer 
 (10 mM HEPES [pH 7.4], 150 mM KCl, 5 mM MgCl2, 0.5 mM dithiothreitol, 100 µg/ml cycloheximide, protease 
inhibitors, and recombinant RNase inhibitors) using a glass teflon homogenizer on ice. Nuclei and debris were 
removed with centrifugation at 2000 x g for 10 min at 4°C. DHPC (Avanti, Alabastar, AL) and NP-40 (Ipgal-ca630, 
Sigma, St Louis, MO) were added to the supernatant (final concentrations of 30mM and 1%, respectively) and 
incubated on ice for 5 minutes. This supernatant was centrifuged at 20,000 x g for 15 minutes at 4°C, and pellet was 
discarded. Protein G-coated magnetic beads (Invitrogen/Life Technologies, Grand Island, NY), conjugated to a mix 
of two monoclonal anti-GFP antibodies (Doyle et al., 2008), and incubated with supernatant by rotation for 30 
minutes at 4°C. Beads were washed three times with high salt wash buffer (10 mM HEPES [pH 7.4], 350 mM KCl, 
5 mM MgCl2, 1% NP-40, 0.5 mM dithiothreitol, and 100 µg/ml cycloheximide). RNA was purified from ribosomes 
using Trizol (Invitrogen), followed by DNAse treatment, further purification, and concentration with RNeasy 
MinElute columns (Qiagen, Hilden, Germany) according to the manufacturers’ protocols. RNA was also harvested 
in parallel from each unbound fraction of affinity purification as a measure of total hindbrain RNA. RNA 
concentration of all samples was measured with Nanodrop spectrophotometer and integrity (RIN>8) was confirmed 
with PicoChips on the Agilent BioAnalyzer.  
Each RNA sample was amplified with the Affymetrix Two-Cycle amplification kit per manufacturer’s instructions. 
Quality of labeled aRNA was assessed with Bioanalyzer. aRNAs from immunoprecipitated ribosomes and total 
tissue were hybridized to separate Affymetrix Mouse Genome 430 2.0 arrays and scanned following manufacturer 
protocols. Raw data are available from the Gene Expression Omnibus (GEO): GSE100005. 
Data were analyzed using the Bioconductor module within the R programming language. Data were normalized as 
described (Dougherty et al., 2010). Briefly, GCRMA was used to normalize within replicates, and to biotinylated 
spike in probes (green dots, Figure 1F) between conditions. Fold change, Specificity Index (SI) and pSI were 
calculated for all genes with expression above non-specific background, and >50 arbitrary fluorescent units, as 
described (Dougherty et al., 2010). The threshold to identify genes expressed above background was conservatively 
set at the mean plus 2 standard deviations of the fold change of negative control transcripts comparing the TRAP 
samples to hindbrain mRNA (Figure 1F, red dots). Genes with expression below this level may or may not be found 
in LC neurons. To identify transcripts enriched in LC neurons compared to hindbrain RNA, we utilized the 
empirical Bayesian statistic with FDR correction within the limma package. Positive control transcripts plotted in 
Figure 1 include genes with known specificity and functionality in LC: Th (Austin et al., 1990; Bacopoulos and 
Bhatnagar, 1977), Ddc (Weihe et al., 2006), Maoa (Hasegawa et al., 1999), Dbh (Swanson and Hartman, 1975), 
Slc18a2 (Weihe et al., 2006), Slc6a2, Gal, GalR1 (Melander et al., 1986), and Phox2a (Morin et al., 1997). We used 
the pSI algorithm with default settings to compare the LC expression profile with other mouse brain cell populations 
characterized by TRAP (Dalal et al., 2013; Dougherty et al., 2013; Doyle et al., 2008; Görlich et al., 2013; Xu et al., 
2014). Cell types included in this analysis are listed in Figure 1G. Hierarchical clustering across cell types was 
conducted in R utilizing expression values from genes with pSI <0.01 in any cell type. Finally, Gene Ontologies 
analysis throughout the manuscript was conducted with the DAVID interface’s Functional Annotation Chart tool 
(Dennis et al., 2003).  
Single animal TRAP for sex-differential and LPS-responsive gene expression.  Four adult male and four adult female 
mice from each of the bacTRAP lines (B6;FVB-Tg (Slc6a4-EGFP/Rpl10a)JD60Htz/J  (Dougherty et al., 2013), and 
B6;FVB-Tg (Slc6a2-EGFP/Rpl10a)JD1538Jdd/J) were surgically implanted with peritoneal G2 E-Mitter 
Transponders (Phillips Respironics), then single-housed for 48 hours to allow continuous telemetric monitoring of 
temperature and activity using the Vital View software and ER-4000 Energizer Receivers. Housing was maintained 
at 30°C (thermoneutral for a mouse) to permit induction of fever (Chai et al., 1996; Gordon, 1993; Kozak et al., 
1998; Leon, 2002). On the day of the experiment, mice were injected at 07:30 AM intraperitoneally with 100 ug/kg 
of LPS (Sigma 0111:B4) or vehicle (sterile PBS) and monitored for lethargy and induction of fever with telemetery. 
Pilot experiments in a separate cohort established that fever peaked around 14:00. Experimental mice were 
euthanized at 14:00-14:30, at which point mice displayed substantial lethargy and a mean fever of 2.175°C ± 1.18 
(SD) above preceding minimal body temperature. Hindbrains were dissected and processed for TRAP as described 
(Heiman et al., 2014). RNA quality was checked as above and quantified with Ribogreen assay. 3-7 ng per sample 
were amplified with Nugen Ovation PicoSL and hybridized to Illumina Mouse WG6 microarrays. Samples were 
handled and hybridized in two batches counterbalanced for mouse line, sex, and LPS exposure. Data were analyzed 
using Bioconductor/R. Examination of distribution of expression levels led to the exclusion of one Slc6a4 TRAP 
sample and two hindbrain samples for poor hybridization. Remaining TRAP and hindbrain samples were separately 
normalized using the lumi package. Appropriate clustering of replicates was confirmed with multidimensional 
 scaling (MDS) (Figure S5). TRAP samples were again compared to hindbrain mRNAs, which confirmed TRAP 
enrichment of markers for each respective cell type. Only genes with TRAP/hindbrain expression above glial 
background (Dougherty et al., 2010) (>0.85 here), and absolute expression >200 fluorescent units were included for 
downstream expression comparisons (sex or LPS/PBS). For each mouse line, probes were defined as differentially 
expressed if p<.05 on a paired T-test (pairing by experimental batch and covariate) and Log2 change was +/- .585 
(1.5 fold) across 3 of 4 paired comparisons. For balance purposes, the remaining replicate was used twice to replace 
the low quality excluded Slc6a4 TRAP sample. Results of these analyses are in Table S1c-S1g. 
Our paired T-test approach accounted for batch effects by design and restricted our candidate DEGs to those with a 
fold-difference in expression of >1.5 across ≥3 of 4 paired comparisons. This achieved our primary goal of 
identifying high-confidence cell-type specific markers and functional targets like Ptger3.  
However, to identify DEGs less stringently (simply a significant average fold-change of 1.5), and to sidestep re-
using samples in paired t-tests, we also performed intercept-free linear modeling analysis in R using the limma 
package on the same microarray data from the Slc6a2-LPS and Slc6a4-LPS experiments. The model was 
implemented using the following formula: 
 
design <- model.matrix(~0+group+batch) 
 
Where the group variable was coded as follows for the Slc6a2 model (and analogously for the Slc6a4 model): 
 
sample_id cell_type treat trap sex Batch group 
A2.P.F.IP_A1 SLC6A2 PBS T F B PBS_F_T 
A2.P.F.IP_C3 SLC6A2 PBS T F A PBS_F_T 
A2.P.M.IP_A3 SLC6A2 PBS T M B PBS_M_T 
A2.P.M.IP_A5 SLC6A2 PBS T M A PBS_M_T 
A2.L.F.IP_A2 SLC6A2 LPS T F B LPS_F_T 
A2.L.F.IP_A6 SLC6A2 LPS T F A LPS_F_T 
A2.L.M.IP_A4 SLC6A2 LPS T M A LPS_M_T 
A2.L.M.IP_C1 SLC6A2 LPS T M B LPS_M_T 
A2.P.F.PRE_D6 SLC6A2 PBS P F A PBS_F_P 
A2.P.F.UB_D1 SLC6A2 PBS P F B PBS_F_P 
A2.P.M.PRE_D4 SLC6A2 PBS P M A PBS_M_P 
A2.P.M.UB_D3 SLC6A2 PBS P M B PBS_M_P 
A2.L.F.PRE_D5 SLC6A2 LPS P F A LPS_F_P 
A2.L.F.UB_D2 SLC6A2 LPS P F B LPS_F_P 
A2.L.M.UB_F1 SLC6A2 LPS P M B LPS_M_P 
 
 
The desired comparisons were made between groups using the following contrasts: 
 
MvF_Trap = (PBS_M_T + LPS_M_T)/2 - (PBS_F_T + LPS_F_T)/2 
LPSvPBS_Trap = (LPS_M_T + LPS_F_T)/2 - (PBS_M_T + PBS_F_T)/2 
MvF_Pre = (PBS_M_P + LPS_M_P)/2 - (PBS_F_P + LPS_F_P)/2 
LPSvPBS_Pre = (LPS_M_P + LPS_F_P)/2 - (PBS_M_P + PBS_F_P)/2 
TrapvPre_M = (PBS_M_T + LPS_M_T)/2 - (PBS_M_P + LPS_M_P)/2 
TrapvPre_F = (PBS_F_T + LPS_F_T)/2 - (PBS_F_P + LPS_F_P)/2 
TrapvPre_LPS = (LPS_M_T + LPS_F_T)/2 - (LPS_M_P + LPS_F_P)/2 
TrapvPre_PBS = (PBS_M_T + PBS_F_T)/2 - (PBS_M_P + PBS_F_P)/2 
 
Note that for assessing main effects of sex or LPS, the available n of LC TRAP samples was 4. We did not examine 
interaction effects for lack of statistical power (n=2 for the cross-comparison). For Slc6a2 mice, this analysis 
 revealed 277 genes with sex-differential upregulation in male Slc6a2 cells and 304 genes with sex-differential 
upregulation in female Slc6a2 cells (including >85% of those from analysis above). This was still substantially 
higher than the sex-differentially upregulated gene sets from Slc6a4 mice (15 genes in male, 15 genes in female). 
Resulting p-values from the latter analytical approach for genes passing differential expression criteria of the former 
approach are included in Table S1c-S1g. Fold changes and p-values from the limma analysis for the entire the entire 
array probeset are in Table S3. 
Motif Analysis of peri-TSS Sequences of Sex-DEGs in LC: sequence acquisition and exon masking. For each sex-
differentially expressed gene identified in the LC (Table S1f,g), mm10 genomic coordinates covering 10kb 5’ and 
10kb 3’ to the canonical TSS were acquired from UCSC genome browser. For genes with multiple transcripts, the 
TSS of the longest transcript was selected. To perform motif discovery strictly within noncoding DNA sequences, 
the coordinates of all exon sequences in each range were acquired from UCSC. The mm10 genome was hard-
masked (e.g., C->N) within all exon coordinates using bedtools maskfasta. The FASTA sequences for the 20kb 
regions were then extracted from the exon-masked genome using bedtools getfasta.  
Conservation scoring and masking prior to MEME. For each base over 20kb regions, PhyloP scores—quantifying 
sequence conservation among placental mammals—were retrieved from UCSC. The threshold for defining 
conservation was a PhyloP score of 0.28, determined by counting the number of bases exceeding a score in steps of 
0.01 and finding the step giving the greatest decrease in number of suprathreshold bases; this score corresponded to 
approximately 25% of input bases. Finally, to smooth the data, we used a “sliding mean” algorithm, acquiring the 
mean PhyloP score 15bp upstream and 15bp downstream of each base, with a step size of 1. Bases falling within ≥ 1 
31bp window with a suprathreshold mean conservation score were retained; all others were hard-masked within the 
existing exon-masked sequences. 
MEME analysis. Masked sequence sets for the male-enriched and female-enriched genes were then submitted to 
MEME (Bailey et al., 2015) for de novo motif analysis for motifs ranging 8-20bp in size. Two analyses were 
performed: one using the –zoops setting, which assumes and detects no more than one instance of a motif in each 
input sequence, and another using the –anr setting, which allows detection of multiple repeats of a motif within a 
given input sequence. The former allows us to detect how many sequences contain a given motif, while the latter 
allows us to detect how many total occurrences of a motif were found. MEME returns E-values, a built-in 
calculation of the likelihood of a motif occurring as many times as observed compared to a MEME-generated 
scrambled version of the input sequence. In the third “discriminative” analysis, one sex’s sequence set was 
submitted as input and the other’s as control, wherein E-scores represent the comparison between the input and 
“control” set, as opposed to input vs. scrambled. “Discriminative mode” in MEME only allows use of the –zoops 
algorithm; therefore, -anr data could not be collected for the direct sequence comparisons. For identification of 
putative TF binding sites represented by these motifs, we submitted the motifs from MEME to another MEME suite 
tool, TomTom, comparing those motifs to known murine and vertebrate TF binding sites (Kulakovskiy et al., 2018; 
Mathelier et al., 2016; Weirauch et al., 2014). 
Chi-square analysis of motif-containing genes in LC sex-enriched sets vs background. To assess whether the 
abundance of these motifs near sex-differentially expressed LC transcripts differed from the genome on the whole, 
1000 random protein-coding TSSes were selected for generation and masking of analogous 20kb windows using the 
same pipeline. These sequences were searched for matches to the discovered motifs using FIMO at the same p cutoff 
for a “match” used during motif discovery. The number of unique genes in the background set containing ≥ 1 
occurrence of the motif was then counted and compared to the sex-differential gene set using chi-square analysis, 
followed by Benjamani-Hochberg correction for twelve tests (one per motif). 
Electrophysiology of LC neurons exposed to PTGER3 agonist/antagonist. Horizontal brain slices were obtained 
from deeply anesthetized 6-7 week old male and female C57/BL6J mice (Jackson Laboratories) containing the LC 
(240 µM), as described (Courtney and Ford, 2014). Briefly, brain slices were cut using a Vibratome (Leica) in warm 
(~30°C) artificial cerebral-spinal fluid (aCSF) solution containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 2.5 
CaCl2, 1.2 NaH2PO4, 21.4 NaHCO3, and 11.1 D-glucose bubbled with 95% O2 and 5% CO2. Slices were incubated 
at 35°C for at least 45 minutes prior to use. MK-801 (10 µM) was included during the incubation to block NMDA 
receptors. Following incubation, slices were transferred to a recording chamber and constantly perfused at 2 ml/min 
with oxygenated aCSF warmed to 34 ± 2°C. Slices were visualized with a BX51WI microscope (Olympus) with 
custom-built infrared gradient contrast optics. 
 Whole-cell recordings were made using an Axopatch 200B amplifier (Molecular Devices). Patch pipettes (2.0-2.5 
MΩ) were pulled from borosilicate glass (World Precision Instruments). For voltage clamp experiments the pipette 
internal solution contained (in mM): 115 K-methylsulphate, 20 NaCl, 1.5 MgCl2, 10 K-HEPES, 10 BAPTA-
tetrapotassium, 2 ATP, 0.3 GTP, and 6 sodium phosphocreatine; pH 7.4; 275 mOsm. LC neurons were held at a 
voltage of -60 mV. No series resistance compensation was used, and cells were discarded if their series resistance 
exceeded 15 MΩ. For current clamp experiments the pipette internal solution contained (in mM): 135 D-gluconate 
(K), 10 HEPES (K), 0.1 CaCl2, 2 MgCl2, 0.1 EGTA, 1 mg/mL ATP, 0.1 mg/mL GTP, and 1.5 mg/mL 
phosphocreatine, pH 7.4, 275 mOsm. Liquid junction potentials were not corrected. All recordings were acquired 
using an ITC-18 interface (Instrutech) and Axograph X (Axograph Scientific) at 5 kHz and filtered to 2 kHz. For 
presentation, long chart recordings were made using a Powerlab 4/20 and LabChart (AD Instruments). Data was 
sampled for presentation at 400 Hz. The LC was identified by its location between the mesencephalic tract motor 
neurons and the 4th ventricle and neurons were identified by a capacitance > 40 pF, an input resistance < 100 MΩ, 
and a tonic firing rate of 0.5 – 4 Hz. Examination of the current-voltage relationship of the sulprostone-evoked 
outward current revealed inward rectification and a hyperpolarized reversal potential (-120 mV). 
Stereotaxic cannulation of LC. Adult male and female C57BL/6J mice (8-10 weeks) were group-housed, given ad 
libitum access to food pellets and water and maintained on a 12/12 hour light:dark cycle (lights on at 6:00 AM). For 
surgery, mice were anesthetized in an induction chamber (4% isoflurane), then placed in a stereotaxic frame (Kopf 
Instruments, Model 1900) where they were maintained at 1-2% isoflurane. We performed craniotomies for insertion 
of two anchor screws and bilateral cannulae (PlasticsOne, Inc.). Cannulae were implanted above the LC (AP -5.45, 
ML +/-1.00, DV -3.00 mm relative to Bregma). Cannulae and anchor screws were then affixed to the skull using 
dental cement. Mice were allowed to recover for 7-9 days prior to behavioral testing. Animals were also habituated 
to handling and connection to pharmacological tubing for 3 consecutive days prior to behavioral testing. 
Sulprostone and vehicle preparation for intracranial infusion. A 10.7mM (5mg/mL) stock solution of sulprostone in 
200uL methyl acetate (Tocris) was diluted with an additional 800uL methyl acetate (Sigma Aldrich) to achieve a 
stock concentration of 1mg/mL. 1.12uL of this solution was then added to 12mL aCSF, achieving a final 
concentration of 200nM (the same concentration applied to ex vivo LC slices). 1.12uL of methyl acetate was added 
to 12mL aCSF for the vehicle-only controls. 
Stress-induced anxiety behavioral paradigm. Mice were intracranially infused via bilateral cannulae with either 
sulprostone (0.4 µL per side, delivering 3.72pg sulprostone per side for drug condition) or its vehicle at a rate of 0.2 
µL/min. Immediately following infusion, all mice were restrained for 30 minutes in 50 mL plastic conical tubes with 
drilled holes permitting air circulation and allowing the tail to extend beyond the tube (adapted from (McCall et al., 
2015)). Immediately following restraint stress, animals were transferred to the open field for a 20-minute test. The 
open field testing (OFT) was performed in a rectangular enclosure 59x39 cm within a sound attenuated enclosure 
with lighting measured and maintained at ~25 lux. The open field was cleaned with 70% ethanol between each trial. 
Mice were returned to their home cage for 50 minutes after OFT; 10 minutes later (60min after the end of OFT), 
isoflurane anesthesia was administered prior to paraformaldehyde perfusion and brain dissection (as previously 
described). For the no-drug (stress vs. no-stress only, Figure 4E-4H), no surgeries or intracranial infusions were 
performed, and this same protocol was used beginning with the 30 minutes of restraint. Anymaze was used for video 
recording of animal movements for center and periphery analysis. The center zone was defined as a concentric 
rectangle comprised of 50% the total area of the OFT arena. Time and frequency in the center was used as a measure 
of anxiety-like behavior. Cannula placement was confirmed by cryostat sectioning of perfused brains to determine 
mice for inclusion in the final behavioral and c-FOS analyses. 
c-FOS quantification in LC following sulprostone/vehicle, restraint, and OFT. Following behavior, perfusion, and 
slicing, 40µm sections of brain containing LC were subjected to immunohistochemistry for phospho-Ser32 c-Fos 
and TH (n=5 vehicle treated males, 5 vehicle-treated females, 4 sulprostone-treated males, 6 sulprostone-treated 
females; see methods described under Immunohistochemistry). Antibodies are described in Table S1j. All sections 
were imaged on a Zeiss AxioScan.Z1 microscope (Karl Zeiss, Germany). Gain, light intensity, and exposure time 
were identical for all prepared microscope slides. All images were processed with the same settings using ImageJ: 
background was first subtracted from the images, ROIs were made around the LC as determined by TH expression, 
and average pixel intensity was measured. Additionally, the number of Fos-expressing and TH-expressing cells were 
counted manually by an experimenter blind to treatment groups. 
Estrous staging of female mice after OFT paradigm. In order to assess whether estrous stages and their 
corresponding hormonal milieus influenced baseline or sulprostone-moderated behaviors, vaginal cytology was 
 performed after female mice were anesthetized, but before perfusion began. Cytology was performed using 100uL 
H2O to perform vaginal lavage, followed by cresyl violet staining of the dried smear as previously described 
(McLean et al., 2012). Estrous stage was assessed as proestrous, estrous, metestrous, or diestrous by light 
microscopy based on cell types and structures (Byers et al., 2012; McLean et al., 2012). 
 
Supplemental References: 
Austin, M.C., Cottingham, S.L., Paul, S.M., and Crawley, J.N. (1990). Tyrosine hydroxylase and galanin mRNA 
levels in locus coeruleus neurons are increased following reserpine administration. Synapse 6, 351–357. 
Bacopoulos, N.G., and Bhatnagar, R.K. (1977). Correlation between tyrosine hydroxylase activity and 
catecholamine concentration or turnover in brain regions. J. Neurochem. 29, 639–643. 
Bailey, T.L., Johnson, J., Grant, C.E., and Noble, W.S. (2015). The MEME Suite. Nucleic Acids Res. 43, W39–49. 
Byers, S.L., Wiles, M.V., Dunn, S.L., and Taft, R.A. (2012). Mouse Estrous Cycle Identification Tool and Images. 
PLOS ONE 7, e35538. 
Chai, Z., Gatti, S., Toniatti, C., Poli, V., and Bartfai, T. (1996). Interleukin (IL)-6 gene expression in the central 
nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J. 
Exp. Med. 183, 311–316. 
Courtney, N.A., and Ford, C.P. (2014). The Timing of Dopamine- and Noradrenaline-Mediated Transmission 
Reflects Underlying Differences in the Extent of Spillover and Pooling. J. Neurosci. 34, 7645–7656. 
Dalal, J., Roh, J.H., Maloney, S.E., Akuffo, A., Shah, S., Yuan, H., Wamsley, B., Jones, W.B., Strong, C. de G., 
Gray, P.A., et al. (2013). Translational profiling of hypocretin neurons identifies candidate molecules for sleep 
regulation. Genes Dev. 27, 565–578. 
Dennis, G., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C., and Lempicki, R.A. (2003). DAVID: 
Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, R60. 
Dougherty, J.D., Schmidt, E.F., Nakajima, M., and Heintz, N. (2010). Analytical approaches to RNA profiling data 
for the identification of genes enriched in specific cells. Nucleic Acids Res. 38, 4218–4230. 
Dougherty, J.D., Maloney, S.E., Wozniak, D.F., Rieger, M.A., Sonnenblick, L., Coppola, G., Mahieu, N.G., Zhang, 
J., Cai, J., Patti, G.J., et al. (2013). The disruption of Celf6, a gene identified by translational profiling of 
serotonergic neurons, results in autism-related behaviors. J. Neurosci. Off. J. Soc. Neurosci. 33, 2732–2753. 
Doyle, J.P., Dougherty, J.D., Heiman, M., Schmidt, E.F., Stevens, T.R., Ma, G., Bupp, S., Shrestha, P., Shah, R.D., 
Doughty, M.L., et al. (2008). Application of a Translational Profiling Approach for the Comparative Analysis of 
CNS Cell Types. Cell 135, 749–762. 
Gordon, C. (1993). Temperature Regulation in Laboratory Rodents (Cambridge University Press). 
Görlich, A., Antolin-Fontes, B., Ables, J.L., Frahm, S., Slimak, M.A., Dougherty, J.D., and Ibañez-Tallon, I. (2013). 
Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons. Proc. 
Natl. Acad. Sci. U. S. A. 110, 17077–17082. 
Hasegawa, Y., Hida, T., and Arai, R. (1999). Noradrenaline-degrading activity of monoamine oxidase is localized in 
noradrenergic neurons of the locus coeruleus of the rat. Neurosci. Lett. 264, 61–64. 
Heiman, M., Kulicke, R., Fenster, R.J., Greengard, P., and Heintz, N. (2014). Cell type–specific mRNA purification 
by translating ribosome affinity purification (TRAP). Nat. Protoc. 9, 1282–1291. 
 Kozak, W., Kluger, M.J., Soszynski, D., Conn, C.A., Rudolph, K., Leon, L.R., and Zheng, H. (1998). IL-6 and IL-1 
beta in fever. Studies using cytokine-deficient (knockout) mice. Ann. N. Y. Acad. Sci. 856, 33–47. 
Kulakovskiy, I.V., Vorontsov, I.E., Yevshin, I.S., Sharipov, R.N., Fedorova, A.D., Rumynskiy, E.I., Medvedeva, 
Y.A., Magana-Mora, A., Bajic, V.B., Papatsenko, D.A., et al. (2018). HOCOMOCO: towards a complete collection 
of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis. Nucleic Acids Res. 
46, D252–D259. 
Leon, L.R. (2002). Invited Review: Cytokine regulation of fever: studies using gene knockout mice. J. Appl. 
Physiol. 92, 2648–2655. 
Mathelier, A., Fornes, O., Arenillas, D.J., Chen, C.-Y., Denay, G., Lee, J., Shi, W., Shyr, C., Tan, G., Worsley-Hunt, 
R., et al. (2016). JASPAR 2016: a major expansion and update of the open-access database of transcription factor 
binding profiles. Nucleic Acids Res. 44, D110-5. 
McCall, J.G., Al-Hasani, R., Siuda, E.R., Hong, D.Y., Norris, A.J., Ford, C.P., and Bruchas, M.R. (2015). CRH 
Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety. Neuron 87, 605–620. 
McLean, A.C., Valenzuela, N., Fai, S., and Bennett, S.A.L. (2012). Performing vaginal lavage, crystal violet 
staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J. Vis. Exp. JoVE e4389–
e4389. 
Melander, T., Hökfelt, T., Rökaeus, A., Cuello, A.C., Oertel, W.H., Verhofstad, A., and Goldstein, M. (1986). 
Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides 
in the rat CNS. J. Neurosci. 6, 3640–3654. 
Morin, X., Cremer, H., Hirsch, M.R., Kapur, R.P., Goridis, C., and Brunet, J.F. (1997). Defects in sensory and 
autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 18, 
411–423. 
Schroeter, S., Apparsundaram, S., Wiley, R.G., Miner, L.H., Sesack, S.R., and Blakely, R.D. (2000). 
Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J. Comp. Neurol. 420, 
211–232. 
Silva, A.F., Sousa, D.S., Medeiros, A.M., Macêdo, P.T., Leão, A.H., Ribeiro, A.M., Izídio, G.S., and Silva, R.H. 
(2016). Sex and Estrous Cycle Influence Diazepam Effects on Anxiety and Memory: Possible Role of Progesterone. 
Prog. Neuropsychopharmacol. Biol. Psychiatry 70, 68–76. 
Swanson, L.W., and Hartman, B.K. (1975). The central adrenergic system. An immunofluorescence study of the 
location of cell bodies and their efferent connections in the rat utilizing dopamine-B-hydroxylase as a marker. J. 
Comp. Neurol. 163, 467–505. 
Weihe, E., Depboylu, C., Schütz, B., Schäfer, M.K.-H., and Eiden, L.E. (2006). Three types of tyrosine 
hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell. Mol. 
Neurobiol. 26, 659–678. 
Weirauch, M.T., Yang, A., Albu, M., Cote, A.G., Montenegro-Montero, A., Drewe, P., Najafabadi, H.S., Lambert, 
S.A., Mann, I., Cook, K., et al. (2014). Determination and Inference of Eukaryotic Transcription Factor Sequence 
Specificity. Cell 158, 1431–1443. 
Xu, X., Wells, A.B., O’Brien, D.R., Nehorai, A., and Dougherty, J.D. (2014). Cell type-specific expression analysis 
to identify putative cellular mechanisms for neurogenetic disorders. J. Neurosci. Off. J. Soc. Neurosci. 34, 1420–
1431. 
 
